Qiaoxuan Wang

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Building Machine Learning Models Based on Oxidative Stress Index Score to Predict Survival of Locally Advanced Rectal Cancer Receiving Different Neoadjuvant Therapy Patterns.

Building Machine Learning Models Based on Oxidative Stress Index Score to Predict Survival of Locally Advanced Rectal Cancer Receiving Different Neoadjuvant Therapy Patterns.

Journal: Diseases of the colon and rectum

Published: August 12, 2026

Local Control in a Retrospective Series of Magnetic Resonance Guided Stereotactic Body Radiation Therapy for Colorectal Liver Metastases: A Single-Institution Experience.

Local Control in a Retrospective Series of Magnetic Resonance Guided Stereotactic Body Radiation Therapy for Colorectal Liver Metastases: A Single-Institution Experience.

Journal: Practical radiation oncology

Published: November 18, 2025

Safety and Efficacy of a Sandwich Total Neoadjuvant Therapy Strategy for Low-Risk Distal Locally Advanced Rectal Cancer: Results From the TESS Phase II Trial.

Safety and Efficacy of a Sandwich Total Neoadjuvant Therapy Strategy for Low-Risk Distal Locally Advanced Rectal Cancer: Results From the TESS Phase II Trial.

Journal: MedComm

Published: August 24, 2025

Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma.

Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: September 13, 2024

FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study.

FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study.

Journal: Journal of hepatocellular carcinoma

Published: September 10, 2024

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: September 05, 2024

Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma.

Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma.

Journal: American journal of cancer research

Published: August 28, 2024

Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Journal: MedComm

Published: May 26, 2024

Microbiota in colorectal cancer related to liver metastasis.

Microbiota in colorectal cancer related to liver metastasis.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: January 12, 2024

Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: December 29, 2022

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.

Journal: Cancer medicine

Published: October 04, 2022

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy.

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy.

Journal: Annals of medicine

Published: March 11, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026